SGLT-2 inhibitors for COVID-19-A miracle waiting to happen or just another beat around the bush?

被引：10

作者：

Chatterjee, Subhankar ^{[1
]}

机构：

[1] Rajendra Inst Med Sci, Dept Gen Med, Ranchi, Jharkhand, India

来源：

PRIMARY CARE DIABETES | 2020年 / 14卷 / 05期

关键词：

NA+/H+; EXCHANGER;

D O I：

10.1016/j.pcd.2020.05.013

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：564 / 565

页数：2

相关论文

共 20 条

[1]

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease [J].

Bonnet, F. ;

Scheen, A. J. .

DIABETES & METABOLISM, 2018, 44 (06) :457-464

[2]

Practical recommendations for the management of diabetes in patients with COVID-19 [J].

Bornstein, Stefan R. ;

Rubino, Francesco ;

Khunti, Kamlesh ;

Mingrone, Geltrude ;

Hopkins, David ;

Birkenfeld, Andreas L. ;

Boehm, Bernhard ;

Amiel, Stephanie ;

Holt, Richard I. G. ;

Skyler, Jay S. ;

DeVries, J. Hans ;

Renard, Eric ;

Eckel, Robert H. ;

Zimmet, Paul ;

George Alberti, Kurt ;

Vidal, Josep ;

Geloneze, Bruno ;

Chan, Juliana C. ;

Ji, Linong ;

Ludwig, Barbara .

LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (06) :546-550

[3]

Endocrine and metabolic link to coronavirus infection [J].

Bornstein, Stefan R. ;

Dalan, Rinkoo ;

Hopkins, David ;

Mingrone, Geltrude ;

Boehm, Bernhard O. .

NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (06) :297-298

[4]

Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? [J].

Carboni, Elena ;

Carta, Anna R. ;

Carboni, Ezio .

MEDICAL HYPOTHESES, 2020, 140

[5]

COVID-19 and diabetes management: What should be considered? [J].

Ceriello, Antonio ;

Stoian, Anca Pantea ;

Rizzo, Manfredi .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163

[6]

SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality? [J].

Chatterjee, Subhankar ;

Bandyopadhyay, Dhrubajyoti ;

Ghosh, Raktim K. ;

Majumdar, Uddalak ;

Aneja, Ashish ;

Lavie, Carl J. ;

Deedwania, Prakash .

CURRENT PROBLEMS IN CARDIOLOGY, 2019, 44 (07) :207-222

[7]

Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19 [J].

Cheng, Hao ;

Wang, Yan ;

Wang, Gui-Qiang .

JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :726-730

[8]

ClinicalTrials.gov, 2020, DAP RESP FAIL PAT CO

[9]

ClinicalTrials.gov, 2020, EFF DPP4 INH COVID 1

[10]

Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis [J].

Cure, Erkan ;

Cure, Medine Cumhur .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :405-406